Insider · CIK 0001875057

Olagunju Peter

Reports to the SEC for 1 company · BOSTON, MA

sec.gov

Transactions

Companies

Filings

CIK

0001875057

Forms 4 and 5

Insider transactions

23 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2023-06-01	TCR2 THERAPEUTICS INC.D Disposition to Issuer	Chief Operating Officer	DDisposition to Issuer	−24.1K sh	—	—	0
2023-06-01	TCR2 THERAPEUTICS INC.Stock Option (Right to Buy)D Disposition to Issuer	Chief Operating Officer	DDisposition to Issuer	−98.1K sh	—	—	0
2023-06-01	TCR2 THERAPEUTICS INC.Stock Option (Right to Buy)D Disposition to Issuer	Chief Operating Officer	DDisposition to Issuer	−47.1K sh	—	—	0
2023-06-01	TCR2 THERAPEUTICS INC.Restricted Stock UnitD Disposition to Issuer	Chief Operating Officer	DDisposition to Issuer	−16.4K sh	—	—	0
2023-06-01	TCR2 THERAPEUTICS INC.Restricted Stock UnitD Disposition to Issuer	Chief Operating Officer	DDisposition to Issuer	−62K sh	—	—	0
2022-12-15	TCR2 THERAPEUTICS INC.Stock Option (Right to Buy)A Award	Chief Operating Officer	AAward	+98.1K sh	—	—	98,124
2022-12-15	TCR2 THERAPEUTICS INC.Restricted Stock Unit (Right to Buy)A Award	Chief Operating Officer	AAward	+16.4K sh	—	—	16,354
2022-12-13	TCR2 THERAPEUTICS INC.S Sale	Chief Operating Officer	SSale	−1,659 sh	$1.06	−$1,766.835	24,092
2022-12-12	TCR2 THERAPEUTICS INC.S Sale	Chief Operating Officer	SSale	−1,610 sh	$1.10	−$1,766.17	25,751
2022-12-09	TCR2 THERAPEUTICS INC.S Sale	Chief Operating Officer	SSale	−1,561 sh	$1.13	−$1,765.491	27,361
2022-12-08	TCR2 THERAPEUTICS INC.S Sale	Chief Operating Officer	SSale	−1,410 sh	$1.25	−$1,766.73	28,922
2022-12-07	TCR2 THERAPEUTICS INC.S Sale	Chief Operating Officer	SSale	−1,378 sh	$1.28	−$1,766.596	30,332
2022-12-06	TCR2 THERAPEUTICS INC.S Sale	Chief Operating Officer	SSale	−1,327 sh	$1.33	−$1,764.91	31,710
2022-12-05	TCR2 THERAPEUTICS INC.S Sale	Chief Operating Officer	SSale	−1,291 sh	$1.37	−$1,766.088	33,037
2022-12-02	TCR2 THERAPEUTICS INC.S Sale	Chief Operating Officer	SSale	−1,273 sh	$1.39	−$1,765.651	34,328
2022-12-01	TCR2 THERAPEUTICS INC.M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	+33.4K sh	—	—	35,601
2022-12-01	TCR2 THERAPEUTICS INC.Restricted Stock UnitM Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	+33.4K sh	—	—	62,047
2022-11-17	TCR2 THERAPEUTICS INC.Stock Option (right to buy)D Disposition to Issuer	Chief Operating Officer	DDisposition to Issuer	−31.5K sh	—	—	0
2022-11-17	TCR2 THERAPEUTICS INC.Restricted Stock Unit (right to buy)A Award	Chief Operating Officer	AAward	+10.5K sh	—	—	10,507
2022-11-17	TCR2 THERAPEUTICS INC.Stock Option (right to buy)D Disposition to Issuer	Chief Operating Officer	DDisposition to Issuer	−255K sh	—	—	0
2022-11-17	TCR2 THERAPEUTICS INC.Restricted Stock Unit (right to buy)A Award	Chief Operating Officer	AAward	+84.9K sh	—	—	84,949
2021-12-09	TCR2 THERAPEUTICS INC.Stock Option (Right to Buy)A Award	Chief Operating Officer	AAward	+47.1K sh	—	—	47,100
2021-07-26	TCR2 THERAPEUTICS INC.Stock Option (Right to Buy)A Award	Chief Operating Officer	AAward	+286K sh	—	—	286,367

Recent filings

Accepted (ET)
Jun 14
Olagunju Peter0001104659-23-067064
SEC(opens sec.gov)
Dec 194
Olagunju Peter0000899243-22-039025
SEC(opens sec.gov)
Dec 134
Olagunju Peter0000899243-22-038384
SEC(opens sec.gov)
Dec 94
Olagunju Peter0000899243-22-038096
SEC(opens sec.gov)
Dec 74
Olagunju Peter0000899243-22-037942
SEC(opens sec.gov)
Dec 54
Olagunju Peter0001209191-22-059882
SEC(opens sec.gov)
Nov 184
Olagunju Peter0000899243-22-036367
SEC(opens sec.gov)

Companies

TCR2 THERAPEUTICS INC.Chief Operating Officer

Address

100 BINNEY STREET

BOSTON, MA, 02142